Neuroimaging Study Group in Movement Disorders

Antonio P. Strafella

 

 

 

 


Chair: Antonio P. Strafella

MDS Staff Liaison: Rachel Bucher

 

MDS Neuroimaging Study Group members gather at the 20th International Congress in Berlin in June 2016.

Steering Committee

Nico Bohnen
Stephane Lehericy
Oury Monchi
Hartwig Siebner
John Stoessl

Standing Members

Angelo Antonini
Benedicte Ballanger
Daniela Berg
David Brooks
Roberto Ceravolo
Roberto Cilia
David Eidelberg
Jennifer G. Goldman
Makoto Higuchi
Simon Lewis
Penny MacDonald
Mario Masellis
Martin McKeown
Ignacio Obeso
Angelo Quartarone
María Rodríguez-Oroz
Nicola Pavese
María Cecilia Peralta
Joel Perlmutter
Paola Piccini
José Ángel Pineda
Marios Politis
Irena Rektorová
James Rowe
Barbara Segura
Klaus Seppi
Alessandro Tessitore
Stephane Thobois
David Vaillancourt
Kaasinen Valtteri
Thilo Van Eimeren
Caroline Williams-Gray

About the Neuroimaging Study Group

Advances in neuroimaging techniques have significantly improved our ability to evaluate basal ganglia functions, to understand the pathophysiology of Parkinson’s disease (PD) and related movement disorders, to diagnose parkinsonian syndromes and monitor disease progression.  Different imaging techniques like positron emission tomography (PET), single-photon emission computed tomography (SPECT), magnetic resonance imaging (MRI) and transcranial sonography, have been used both in patient and animal models to investigate neuropathological mechanisms and/or compensatory changes underlying symptoms (i.e. motor and non-motor), treatment-related complications (e.g. impulse control disorders), and to monitor progression.

The overall objective of this MDS study group proposal is to bring together clinical and preclinical experts from different neuroimaging research backgrounds who are engaged in investigations relevant to human brain organization applied to movement disorders. Discussion will center on current knowledge of advanced, cutting-edge imaging techniques and their actions at the molecular and network/system level, both in patients and animal models. One aim of this study group is to apply a “bench-to-bedside” translational approach with a focus on various imaging techniques (e.g. molecular PET imaging, high-field MRI). These discussions will foster new international collaborations and study proposals centered on clinical, preclinical, and translational approaches to develop innovative initiatives of neuroimaging research for movement disorders. 

Mission and Objectives
  • To work on the current understanding of different molecular PET imaging techniques (receptor abnormalities, protein deposition, neuroinflammation, etc.) and their clinical relevance to movement disorders
  • To update about high-field MRI techniques and various new imaging analysis (e.g. graph-theory modality) for anatomical and functional connectivity exploring the dynamic interaction between pathological processes and functional organization of the human brain in movement disorders
  • To provide an update on the current status of animal imaging for PET and high-field MRI 
  • To facilitate and promote cross-collaboration among experts from these various fields with the objective of expanding understanding and knowledge boundaries and raising important questions on general feasibility and clinical applicability of new technologies
  • To discuss potential multidisciplinary initiatives for new cutting-edge neuroimaging studies focusing on Parkinson's disease, atypical parkinsonisms and other movement disorders
Top

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. The MDS site uses multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice